271 related articles for article (PubMed ID: 31258144)
41. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
42. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface.
Kunzelmann-Marche C; Satta N; Toti F; Zhang Y; Nawroth PP; Morrissey JH; Freyssinet JM
Thromb Haemost; 2000 Feb; 83(2):282-9. PubMed ID: 10739387
[TBL] [Abstract][Full Text] [Related]
43. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
44. Tissue factor activity in whole blood.
Butenas S; Bouchard BA; Brummel-Ziedins KE; Parhami-Seren B; Mann KG
Blood; 2005 Apr; 105(7):2764-70. PubMed ID: 15604222
[TBL] [Abstract][Full Text] [Related]
45. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation.
Davila M; Amirkhosravi A; Coll E; Desai H; Robles L; Colon J; Baker CH; Francis JL
J Thromb Haemost; 2008 Sep; 6(9):1517-24. PubMed ID: 18433463
[TBL] [Abstract][Full Text] [Related]
46. Dissimilarity of increased phosphatidylserine-positive microparticles and associated coagulation activation in acute coronary syndromes.
Liu Y; He Z; Zhang Y; Dong Z; Bi Y; Kou J; Zhou J; Shi J
Coron Artery Dis; 2016 Aug; 27(5):365-75. PubMed ID: 27058313
[TBL] [Abstract][Full Text] [Related]
47. Daunorubicin induces procoagulant activity of cultured endothelial cells through phosphatidylserine exposure and microparticles release.
Fu Y; Zhou J; Li H; Cao F; Su Y; Fan S; Li Y; Wang S; Li L; Gilbert GE; Shi J
Thromb Haemost; 2010 Dec; 104(6):1235-41. PubMed ID: 20886178
[TBL] [Abstract][Full Text] [Related]
48. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment.
Chou ML; Lin LT; Devos D; Burnouf T
Transfusion; 2015 Oct; 55(10):2433-44. PubMed ID: 25988671
[TBL] [Abstract][Full Text] [Related]
49. Phosphatidylserine-exposing tumor-derived microparticles exacerbate coagulation and cancer cell transendothelial migration in triple-negative breast cancer.
Zhang C; Yang Z; Zhou P; Yu M; Li B; Liu Y; Jin J; Liu W; Jing H; Du J; Tian J; Zhao Z; Wang J; Chu Y; Zhang C; Novakovic VA; Shi J; Wu C
Theranostics; 2021; 11(13):6445-6460. PubMed ID: 33995667
[No Abstract] [Full Text] [Related]
50. Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation?
Davila M; Robles-Carrillo L; Unruh D; Huo Q; Gardiner C; Sargent IL; Adam M; Woodhams BJ; Francis JL; Bogdanov VY; Amirkhosravi A
J Thromb Haemost; 2014 Feb; 12(2):186-96. PubMed ID: 24298933
[TBL] [Abstract][Full Text] [Related]
51. Intravascular cells and circulating microparticles induce procoagulant activity via phosphatidylserine exposure in heart failure.
Kou Y; Zou L; Liu R; Zhao X; Wang Y; Zhang C; Dong Z; Kou J; Bi Y; Fu L; Shi J
J Thromb Thrombolysis; 2019 Aug; 48(2):187-194. PubMed ID: 31177487
[TBL] [Abstract][Full Text] [Related]
52. Microparticles profiling in trauma patients: high level of microparticles induce activation of platelets in vitro.
Caspers M; Schäfer N; Fröhlich M; Bouillon B; Mutschler M; Bauerfeind U; Maegele M
Eur J Trauma Emerg Surg; 2020 Feb; 46(1):43-51. PubMed ID: 30864053
[TBL] [Abstract][Full Text] [Related]
53. Initiation of coagulation by tissue factor carriers in blood.
Engelmann B
Blood Cells Mol Dis; 2006; 36(2):188-90. PubMed ID: 16473535
[TBL] [Abstract][Full Text] [Related]
54. Indolic uremic solutes enhance procoagulant activity of red blood cells through phosphatidylserine exposure and microparticle release.
Gao C; Ji S; Dong W; Qi Y; Song W; Cui D; Shi J
Toxins (Basel); 2015 Oct; 7(11):4390-403. PubMed ID: 26516916
[TBL] [Abstract][Full Text] [Related]
55. Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma.
Yuana Y; Osanto S; Bertina RM
Blood Coagul Fibrinolysis; 2012 Apr; 23(3):244-50. PubMed ID: 22343682
[TBL] [Abstract][Full Text] [Related]
56. Cell-derived microparticles promote coagulation after moderate exercise.
Sossdorf M; Otto GP; Claus RA; Gabriel HH; Lösche W
Med Sci Sports Exerc; 2011 Jul; 43(7):1169-76. PubMed ID: 21131870
[TBL] [Abstract][Full Text] [Related]
57. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
Woei-A-Jin FJ; van der Starre WE; Tesselaar ME; Garcia Rodriguez P; van Nieuwkoop C; Bertina RM; van Dissel JT; Osanto S
Thromb Res; 2014 May; 133(5):799-803. PubMed ID: 24657035
[TBL] [Abstract][Full Text] [Related]
58. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation.
Lacroix R; Dignat-George F
Thromb Res; 2012 May; 129 Suppl 2():S27-9. PubMed ID: 22424856
[TBL] [Abstract][Full Text] [Related]
59. Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation.
Meng S; Kang K; Fei D; Yang S; Gu Q; Pan S; Zhao M
J Int Med Res; 2021 May; 49(5):3000605211014094. PubMed ID: 34034547
[TBL] [Abstract][Full Text] [Related]
60. Contributions of phosphatidylserine-positive platelets and leukocytes and microparticles to hypercoagulable state in gastric cancer patients.
Yang C; Ma R; Jiang T; Cao M; Zhao L; Bi Y; Kou J; Shi J; Zou X
Tumour Biol; 2016 Jun; 37(6):7881-91. PubMed ID: 26700666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
